New York, April 29, 2016 -- Moody's Investors Service commented that Alere Inc.'s (B2 RUR Up) receipt of an amendment and waiver related to its senior secured credit facilities is a positive development. There are no changes to our ratings, including the B2 Corporate Family Rating, B2-PD Probability of Default Rating, Ba3 senior secured rating, B3 senior unsecured rating, or Caa1 senior subordinated rating at this time. These ratings remain on review for upgrade on the pending acquisition by Abbott Laboratories (A2 RUR Down). On April 28th, in Abbott's call to discuss its acquisition of St. Jude Medical (Baa2 RUR Down), management stated that its financing plan contemplates the completion of both the St. Jude and Alere acquisitions.

Vollständigen Artikel bei Moodys lesen